Patents by Inventor Itay Perlstein

Itay Perlstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240315997
    Abstract: Disclosed is a method for the treatment of a neurological or movement disorder. e.g., Parkinson's disease, in an individual in need thereof, by parenteral administration of levodopa, a levodopa salt, a levodopa prodrug, or any combination thereof, and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, a carbidopa salt, a carbidopa prodrug, benserazide or any combination thereof, concomitantly with oral administration of levodopa, a DDCI, such as carbidopa, benserazide, or any combination thereof.
    Type: Application
    Filed: October 26, 2023
    Publication date: September 26, 2024
    Applicant: NeuroDerm, Ltd.
    Inventors: Tal Birnberg, Shmuel Ben Eliahu, Natalia Vostokova, Danit Finkelshtein Beker, Liat Adar, Itay Perlstein
  • Patent number: 11844754
    Abstract: Disclosed is a method for the treatment of a neurological or movement disorder, e.g., Parkinson's disease, in an individual in need thereof, by parenteral administration of levodopa, a levodopa salt, a levodopa prodrug, or any combination thereof, and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, a carbidopa salt, a carbidopa prodrug, benserazide or any combination thereof, concomitantly with oral administration of levodopa, a DDCI, such as carbidopa, benserazide, or any combination thereof.
    Type: Grant
    Filed: January 3, 2023
    Date of Patent: December 19, 2023
    Assignee: NeuroDerm, Ltd.
    Inventors: Tal Birnberg, Shmuel Ben Eliahu, Natalia Vostokova, Danit Finkelshtein Beker, Liat Adar, Itay Perlstein
  • Publication number: 20230157985
    Abstract: Disclosed is a method for the treatment of a neurological or movement disorder, e.g.
    Type: Application
    Filed: January 3, 2023
    Publication date: May 25, 2023
    Inventors: Tal Birnberg, Shmuel Ben Eliahu, Natalia Vostokova, Danit Finkelshtein Beker, Liat Adar, Itay Perlstein
  • Publication number: 20230064357
    Abstract: Disclosed is a method for the treatment of a neurological or movement disorder, e.g., Parkinson’s disease, in an individual in need thereof, by parenteral administration of levodopa and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, benserazide or any combination thereof, concomitantly with oral administration of levodopa, a DDCI, such as carbidopa, benserazide, or any combination thereof.
    Type: Application
    Filed: April 14, 2022
    Publication date: March 2, 2023
    Inventors: Tal Birnberg, Liat Adar, Itay Perlstein
  • Patent number: 11458115
    Abstract: Disclosed is a method for the treatment of a neurological or movement disorder, e.g., Parkinson's disease, in an individual in need thereof, by parenteral administration of levodopa and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, benserazide or any combination thereof, concomitantly with oral administration of levodopa, a DDCI, such as carbidopa, benserazide, or any combination thereof.
    Type: Grant
    Filed: May 4, 2022
    Date of Patent: October 4, 2022
    Assignee: NeuroDerm, Ltd.
    Inventors: Tal Birnberg, Liat Adar, Itay Perlstein
  • Publication number: 20220257549
    Abstract: Disclosed is a method for the treatment of a neurological or movement disorder, e.g., Parkinson's disease, in an individual in need thereof, by parenteral administration of levodopa and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, benserazide or any combination thereof, concomitantly with oral administration of levodopa, a DDCI, such as carbidopa, benserazide, or any combination thereof.
    Type: Application
    Filed: May 4, 2022
    Publication date: August 18, 2022
    Inventors: Tal Birnberg, Liat Adar, Itay Perlstein
  • Publication number: 20220151967
    Abstract: Disclosed is a method for the treatment of a neurological or movement disorder, e.g., Parkinson's disease, in an individual in need thereof, by parenteral administration of levodopa and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, benserazide or any combination thereof, concomitantly with oral administration of levodopa, a DDCI, such as carbidopa, benserazide, or any combination thereof.
    Type: Application
    Filed: January 3, 2022
    Publication date: May 19, 2022
    Inventors: Tal Birnberg, Liat Adar, Itay Perlstein
  • Publication number: 20220151965
    Abstract: Disclosed is a method for the treatment of a neurological or movement disorder, e.g., Parkinson's disease, in an individual in need thereof, by parenteral administration of levodopa and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, benserazide or any combination thereof, concomitantly with oral administration of levodopa, a DDCI, such as carbidopa, benserazide, or any combination thereof.
    Type: Application
    Filed: November 23, 2021
    Publication date: May 19, 2022
    Inventors: Tal Birnberg, Liat Adar, Itay Perlstein
  • Patent number: 11331293
    Abstract: Disclosed is a method for the treatment of a neurological or movement disorder, e.g., Parkinson's disease, in an individual in need thereof, by parenteral administration of levodopa and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, benserazide or any combination thereof, concomitantly with oral administration of levodopa, a DDCI, such as carbidopa, benserazide, or any combination thereof.
    Type: Grant
    Filed: January 3, 2022
    Date of Patent: May 17, 2022
    Assignee: NeuroDerm, Ltd.
    Inventors: Tal Birnberg, Liat Adar, Itay Perlstein
  • Patent number: 11213502
    Abstract: Disclosed is a method for the treatment of a neurological or movement disorder, e.g., Parkinson's disease, in an individual in need thereof, by parenteral administration of levodopa and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, benserazide or any combination thereof, concomitantly with oral administration of levodopa, a DDCI, such as carbidopa, benserazide, or any combination thereof.
    Type: Grant
    Filed: May 28, 2021
    Date of Patent: January 4, 2022
    Assignee: NeuroDerm, Ltd.
    Inventors: Tal Birnberg, Liat Adar, Itay Perlstein
  • Publication number: 20140058954
    Abstract: A searchable matching system and method with customizable profiles and pre-interview negotiation bidding is provided. The system comprises a central website connected to a database of multimedia data related to end users customizable profiles and listings. Pre-matched searchable fields, used in profile creation facilitate matching of end users with the maximum relevancy of fields, and search results are ranked. The system includes communication, interviewing, and scheduling modules. End users negotiate terms of an agreement through placing and/or receiving bids upfront before interviewing, wherein bid terms limit the scope of the potential agreement, which can be accepted by end users making the terms of said bids binding for future negotiations. Only when users enter into a final agreement will final terms of negotiation bids become binding upon all users. Preferred industries include job placement services, landlord and tenant matching services, travel services, or real estate finding services.
    Type: Application
    Filed: August 19, 2013
    Publication date: February 27, 2014
    Inventors: Merav Yonit Perlstein, Itay Perlstein